Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune response-related gene transcripts represent the diverse collection of messenger RNA (mRNA) molecules transcribed from genes that orchestrate the host's immune system. This broad category includes transcripts encoding cytokines, chemokines, pattern recognition receptors, and major histocompatibility complex (MHC) molecules, which are essential for detecting and responding to pathogens and cellular stress. In clinical and pharmaceutical research, these transcripts are primarily utilized as biomarkers to monitor the immune landscape of tissues, particularly in oncology and autoimmune disorders. While the entire set of transcripts is not a single drug target, individual transcripts within this group are targeted by RNA-based therapeutics, and their collective expression levels are modulated by broad-acting immunomodulatory drugs. Understanding the dynamics of these transcripts is crucial for patient stratification and for evaluating the efficacy of immunotherapies.
Modulation of gene expression through transcriptional regulation, mRNA stability, or signaling pathway inhibition
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune response-related gene transcripts (IRGs).